US Stock MarketDetailed Quotes
MDGL Madrigal Pharmaceuticals
- 329.240
- +12.150+3.83%
Close Nov 21 16:00 ET
- 329.240
- 0.0000.00%
Post 20:01 ET
7.18BMarket Cap-13153P/E (TTM)
329.930High315.150Low423.64KVolume318.420Open317.090Pre Close137.70MTurnover4.04%Turnover RatioLossP/E (Static)21.81MShares368.29052wk High9.24P/B3.45BFloat Cap168.24652wk Low--Dividend TTM10.49MShs Float415.800Historical High--Div YieldTTM4.66%Amplitude6.600Historical Low325.051Avg Price1Lot Size
About Madrigal Pharmaceuticals Company
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West Conshohocken, PA.
Company Profile
SymbolMDGL
Company NameMadrigal Pharmaceuticals
Listing DateFeb 6, 2007
Issue Price12.01
Founded2000
CEOMr. William John (Bill) Sibold
MarketNASDAQ
Employees276
Fiscal Year Ends12-31
Address200 Barr Harbor Drive,Suite 200
CityWest Conshohocken
ProvincePennsylvania
CountryUnited States of America
Zip Code19428
Phone1-267-824-2827
Company Executives
- Name
- Position
- Salary
- William John (Bill) Sibold
- Director, President and Chief Executive Officer
- 32.27M
- Carole Huntsman
- Chief Commercial Officer
- 3.14M
- Dr. Robert E. Waltermire, PhD
- Chief Pharmaceutical Development Officer
- --
- Mardi C. Dier
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Rebecca A. Taub,M.D.
- Director, Chief Medical Officer and President, Research and Development
- 6.93M
- Julian C. Baker
- Chairman of the Board
- 646.00K
- Dr. Paul A. Friedman,M.D.
- Director
- 10.63K
- Dr. Frederick B. Craves, PhD
- Lead Independent Director
- 371.13K
- Raymond Cheong, M.D.,PhD
- Independent Director
- 639.75K
- Dr. Richard S. Levy,M.D.
- Independent Director
- 368.63K
- Kenneth M. Bate
- Independent Director
- 383.63K
- James M. Daly
- Independent Director
- 363.63K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data